With our end-to-end traceability solutions, OPTEL is currently helping pharmaceutical manufacturers, wholesalers and dispensers across Europe to ensure compliance with the European Union Falsified Medicines Directive (EU FMD).
In response to the alarming increase in substandard or counterfeit medications, the European Union adopted the FMD, or regulation (EU) 2016/161, on 2 October 2015, and subsequently published it on 9 February 2016. This legislation states that, by 9 February 2019, European hospitals and retail pharmacies will be required to decommission prescription medications using unique identifiers before distributing them to patients.
The road to compliance is short and difficult to navigate. As a leading provider of traceability systems since 1989, OPTEL can act as a trustworthy partner, supporting pharmacists and staff with guidance as well as effective, ready-to-use solutions to help you achieve compliance and much more.
OPTEL Certa™ Software performs barcode verification as well as decommissioning of prescription medication. With its safe and secure communication with the National Medicines Verification Systems (NMVS) of countries across the European Union, this unique product provides healthcare professionals with an immediate solution for compliance with the EU FMD.
OPTEL Certa™ Software can integrate into our flexible hardware devices or simply connect to your pharmacy systems.
We understand that verification and decommissioning are added steps to your workflow operations. See how our solution can easily integrate into your daily operations.
How many packs per day do you dispense? Tell us more about your pharmacy.
Take a look at the events we have attented, as well as the ones we will attend next. See you soon!
OPTEL GROUP, announce that it is now officially connected to the Irish Medicines Verification Organisation (IMVO), part of the European Medicines Verification System (EMVS).
Let our experts help you understand the particularities of the EU FMD and how you can comply.
